Wenwen Chai
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
AL2846, a Novel Multi-Kinase Inhibitor, for Previously Treated Radioiodine-Refractory Differentiated Thyroid Cancer: Exploratory Clinical Results From the Phase Ib Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 22, 2025
Endogenous S100P-mediated autophagy regulates the chemosensitivity of leukemia cells through the p53/AMPK/mTOR pathway.
Journal: American journal of cancer research
Published: September 10, 2023
Knockdown of HMGB1 Suppresses Hypoxia-Induced Mitochondrial Biogenesis in Pancreatic Cancer Cells.
Journal: OncoTargets and therapy
Published: October 15, 2019
HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 02, 2019
HMGB1 regulates erastin-induced ferroptosis via RAS-JNK/p38 signaling in HL-60/NRASQ61L cells.
Journal: American journal of cancer research
Published: February 01, 2019
Ataxia-telangiectasia with a novel ATM gene mutation and Burkitt leukemia: A case report.
Journal: Molecular and clinical oncology
Published: August 09, 2018
HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells.
Journal: Oncotarget
Published: September 23, 2016
Knockdown of WAVE1 enhances apoptosis of leukemia cells by downregulating autophagy.
Journal: International journal of oncology
Published: January 16, 2016
Reactive oxygen species regulate the differentiation of acute promyelocytic leukemia cells through HMGB1-mediated autophagy.
Journal: American journal of cancer research
Published: October 13, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026